Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.005 per share
-
Shares outstanding
-
110,002,045
-
Total 13F shares
-
329,815
-
Share change
-
+268,626
-
Total reported value
-
$1,192,085
-
Price per share
-
$3.22
-
Number of holders
-
18
-
Value change
-
+$995,056
-
Number of buys
-
17
Institutional Holders of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) as of Q4 2022
As of 31 Dec 2022,
Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
329,815 shares.
The largest 10 holders included
Cypress Point Wealth Management, LLC, Naviter Wealth, LLC, CI Private Wealth, LLC, VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BALDWIN BROTHERS LLC/MA, MORGAN STANLEY, and CREDIT SUISSE AG/.
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.